There was a promising (or surprising) rise in corporate-backed funding rounds for cryptocurrency startups in November. Despite many heralding the demise of crypto, it looks like it isn't dead yet.

CEO Ophir Gaathon tells us why Airbus and American Express have backed Dust Identity, and how diamond dust can track data on objects through the supply chain.

Qualcomm and Volkswagen are among the companies that backed connected car technology provider Cubic Telecom at a $215m valuation that has been pushed past the $1bn mark.

OVO is set to acquire EV charging dats company Bonnet. Read the full round-up of corporate venture activity in November.

Access Industries, GV and Coinbase Ventures all took part in one of the year's biggest Web3 funding rounds.

Several corporate investors were involved in Seurat raising $99m, promising increased speed and precision for its metal printing technology along with a lower carbon footprint.

WeBuy Global and J&T Global Express announce IPOs, Payzer is acquired and news funds launched.

Husk Power Systems has just raised $100m from investors including Shell to build 1,500 solar mini-grids in India and Nigeria in the next four to five years.

Funding in every other sector continues to decline but industrial startups solving climate change and logistics problems are in vogue.

HR software provider Employment Hero has scored a unicorn valuation as it looks to strengthen its international presence - and Seek could have the ideal CVC profile to help.

Ten corporate investors were part of a $380m series C round this week, including Fortescue, United Airlines, Rio Tinto, Amazon, Microsoft and BP.

Unearth Technologies is acquired and Tuhu Car undergoes an IPO - read the full round up of corporate venture activity in September.

The week saw two billion-dollar rounds for the first time since the 2021 boom, but Anthropic and Rox Motor typify the top of a market increasingly concentrated in two areas.

The corporate-backed shopping service floated in a $660m offering this week, alongside Klaviyo, RayzeBio and Neumora, but investors may have to pay a price for their IPO exits.